Share on StockTwits

Integra Lifesciences Holdings Corp (NASDAQ:IART) VP Judith Ogrady sold 2,500 shares of Integra Lifesciences Holdings Corp stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $49.82, for a total value of $124,550.00. Following the completion of the transaction, the vice president now directly owns 10,706 shares of the company’s stock, valued at approximately $533,373. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Oppenheimer reiterated an “outperform” rating on shares of Integra Lifesciences Holdings Corp in a research note on Wednesday, August 6th. They now have a $57.00 price target on the stock, up previously from $55.00. Analysts at Jefferies Group raised their price target on shares of Integra Lifesciences Holdings Corp from $54.00 to $57.00 in a research note on Wednesday, August 6th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $52.57.

Shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) traded down 0.18% during mid-day trading on Thursday, hitting $49.52. The stock had a trading volume of 95,616 shares. Integra Lifesciences Holdings Corp has a 1-year low of $37.92 and a 1-year high of $51.32. The stock’s 50-day moving average is $48.57 and its 200-day moving average is $46.78. The company’s market cap is $1.614 billion.

Integra Lifesciences Holdings Corp (NASDAQ:IART) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.04. The company had revenue of $231.40 million for the quarter, compared to the consensus estimate of $229.32 million. During the same quarter in the previous year, the company posted $0.60 earnings per share. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. On average, analysts predict that Integra Lifesciences Holdings Corp will post $2.94 earnings per share for the current fiscal year.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) is an integrated medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.